Download PDF
Facial Plast Surg 2014; 30(06): 615-622
DOI: 10.1055/s-0034-1396904
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Complications of Collagen Fillers

Patricia Lucey
1   Department of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, New York, New York
,
David J. Goldberg
2   Skin Laser and Surgery Specialists of NY/NJ, New Jersey
3   Department of Dermatology, Mount Sinai School of Medicine, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
23 December 2014 (online)

    Permissions and Reprints

Abstract

As the skin ages, a deficiency in collagen occurs, thus injectable collagen products have become a sensible and popular option for dermal filling and volume enhancement. Several types of collagen have been developed over the years, including animal sources such as bovine and porcine collagen, as well as human-based sources derived from pieces of the patient's own skin, cadaver skin, and later cultured from human dermal fibroblasts. While collagen overall has a relatively safe, side effect profile, there are several complications, both early and late onset, that practitioners and patients should be aware of. Early complications, occurring within days of the procedure, can be divided into non-hypersensitivity and hypersensitivity reactions. The non-hypersensitive reactions include injection site reactions, discoloration, maldistribution, infection, skin necrosis, and the very rare but dreaded risk of vision loss, whereas the hypersensitivity reactions present usually as delayed type IV reactions, but can also rarely present as an immediate type I reaction. Late complications, occurring within weeks to even years after injection, include granuloma formation, foreign body reactions, and infection secondary to atypical mycobacteria or biofilms. This review will give a detailed overview of the complications secondary to cutaneous collagen injections.

Keywords

collagen - dermal fillers - injections - complications

Note

The authors have not received any financial support or personal assistance for this study.


 

  • References

  • 1 Baumann L, Kaufman J, Saghari S. Collagen fillers. Dermatol Ther 2006; 19 (3) 134-140
    CrossrefPubMedGoogle Scholar
  • 2 Lavker RM. Structural alterations in exposed and unexposed aged skin. J Invest Dermatol 1979; 73 (1) 59-66
    CrossrefPubMedGoogle Scholar
  • 3 Fisher GJ, Datta SC, Talwar HS , et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379 (6563) 335-339
    CrossrefPubMedGoogle Scholar
  • 4 Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997; 337 (20) 1419-1428
    CrossrefPubMedGoogle Scholar
  • 5 Cockerham K, Hsu VJ. Collagen-based dermal fillers: past, present, future. Facial Plast Surg 2009; 25 (2) 106-113
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 2011; 64 (1) 1-34 , quiz 35–36
    Google Scholar
  • 7 Sánchez-Carpintero I, Candelas D, Ruiz-Rodríguez R. Dermal fillers: types, indications, and complications [in Spanish]. Actas Dermosifiliogr 2010; 101 (5) 381-393
    CrossrefPubMedGoogle Scholar
  • 8 Bailey SH, Cohen JL, Kenkel JM. Etiology, prevention, and treatment of dermal filler complications. Aesthet Surg J 2011; 31 (1) 110-121
    CrossrefPubMedGoogle Scholar
  • 9 Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34 (Suppl. 01) S92-S99
    CrossrefPubMedGoogle Scholar
  • 10 Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003; 29 (6) 573-587 , discussion 587
    CrossrefPubMedGoogle Scholar
  • 11 Hirsch RJ, Stier M. Complications of soft tissue augmentation. J Drugs Dermatol 2008; 7 (9) 841-845
    PubMedGoogle Scholar
  • 12 Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 1991; 25 (2 Pt 1) 319-326
    CrossrefPubMedGoogle Scholar
  • 13 Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: management of rare events following dermal fillers—focal necrosis and angry red bumps. Dermatol Surg 2006; 32 (3) 426-434
    CrossrefPubMedGoogle Scholar
  • 14 Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg 2006; 32 (2) 276-281
    PubMedGoogle Scholar
  • 15 Castrow II FF, Krull EA. Injectable collagen implant—update. J Am Acad Dermatol 1983; 9 (6) 889-893
    CrossrefPubMedGoogle Scholar
  • 16 DeLustro F, Smith ST, Sundsmo J, Salem G, Kincaid S, Ellingsworth L. Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg 1987; 79 (4) 581-594
    CrossrefPubMedGoogle Scholar
  • 17 McGrew RN, Wilson RS, Havener WH. Sudden blindness secondary to injections of common drugs in the head and neck: I. Clinical experiences. Otolaryngology 1978; 86 (1) ORL-147-ORL-151
    PubMedGoogle Scholar
  • 18 Silva MT, Curi AL. Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr 2004; 62 (3B, 3b): 873-874
    CrossrefPubMedGoogle Scholar
  • 19 Braun M, Braun S. Nodule formation following lip augmentation using porcine collagen-derived filler. J Drugs Dermatol 2008; 7 (6) 579-581
    PubMedGoogle Scholar
  • 20 Klein AW. Skin filling. Collagen and other injectables of the skin. Dermatol Clin 2001; 19 (3) 491-508 , ix
    CrossrefPubMedGoogle Scholar
  • 21 Siegle RJ, McCoy Jr JP, Schade W, Swanson NA. Intradermal implantation of bovine collagen. Humoral immune responses associated with clinical reactions. Arch Dermatol 1984; 120 (2) 183-187
    CrossrefPubMedGoogle Scholar
  • 22 Glavas IP. Filling agents. Ophthalmol Clin North Am 2005; 18 (2) 249-257 , v–vi
    CrossrefPubMedGoogle Scholar
  • 23 Pollack S. Some new injectable dermal filler materials: Hylaform, Restylane, and Artecoll. J Cutan Med Surg 1999; 3 (Suppl. 04) S27-S35
    PubMedGoogle Scholar
  • 24 Moody BR, Sengelmann RD. Topical tacrolimus in the treatment of bovine collagen hypersensitivity. Dermatol Surg 2001; 27 (9) 789-791
    PubMedGoogle Scholar
  • 25 Baumann LS, Kerdel F. The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg 1999; 25 (3) 247-249
    CrossrefPubMedGoogle Scholar
  • 26 Douglas RS, Donsoff I, Cook T, Shorr N. Collagen fillers in facial aesthetic surgery. Facial Plast Surg 2004; 20 (2) 117-123
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons. Aust N Z J Ophthalmol 1996; 24 (3) 257-260
    CrossrefPubMedGoogle Scholar
  • 28 Stolman LP. Human collagen reactions. Dermatol Surg 2005; 31 (11, Pt 2) 1634
    CrossrefPubMedGoogle Scholar
  • 29 Barr RJ, King DF, McDonald RM, Bartlow GA. Necrobiotic granulomas associated with bovine collagen test site injections. J Am Acad Dermatol 1982; 6 (5) 867-869
    CrossrefPubMedGoogle Scholar
  • 30 Rapaport MJ. Granuloma annulare caused by injectable collagen. Arch Dermatol 1984; 120 (7) 837-838
    CrossrefPubMedGoogle Scholar
  • 31 García-Domingo MI, Alijotas-Reig J, Cisteró-Bahima A, Tresserra F, Enrique E. Disseminated and recurrent sarcoid-like granulomatous panniculitis due to bovine collagen injection. J Investig Allergol Clin Immunol 2000; 10 (2) 107-109
    PubMedGoogle Scholar
  • 32 Brongo S, Moccia LS, Nunziata V, D'Andrea F. Keratoacanthoma arising after site injection infection of cosmetic collagen filler. Int J Surg Case Rep 2013; 4 (4) 429-431
    CrossrefPubMedGoogle Scholar
  • 33 Fischer J, Metzler G, Schaller M. Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. Arch Dermatol 2007; 143 (4) 507-510
    CrossrefPubMedGoogle Scholar
  • 34 Piacquadio D, Smith S, Anderson R. A comparison of commercially available polymethylmethacrylate-based soft tissue fillers. Dermatol Surg 2008; 34 (Suppl. 01) S48-S52
    PubMedGoogle Scholar
  • 35 Lemperle G, Hazan-Gaúthier N, Lemperle M. PMMA microspheres (Artecoll) for skin and soft-tissue augmentation. Part II: Clinical investigations. Plast Reconstr Surg 1995; 96 (3) 627-634
    CrossrefPubMedGoogle Scholar
  • 36 Alcalay J, Alkalay R, Gat A, Yorav S. Late-onset granulomatous reaction to Artecoll. Dermatol Surg 2003; 29 (8) 859-862
    CrossrefPubMedGoogle Scholar
  • 37 Requena C, Izquierdo MJ, Navarro M , et al. Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol 2001; 23 (3) 197-202
    CrossrefPubMedGoogle Scholar
  • 38 Reisberger EM, Landthaler M, Wiest L, Schröder J, Stolz W. Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol 2003; 139 (1) 17-20
    CrossrefPubMedGoogle Scholar
  • 39 Conejo-Mir JS, Sanz Guirado S, Angel Muñoz M. Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg 2006; 32 (8) 1079-1081 , discussion 1082
    PubMedGoogle Scholar
  • 40 Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg 2003; 29 (9) 971-973
    Google Scholar
  • 41 Bentkover SH. The biology of facial fillers. Facial Plast Surg 2009; 25 (2) 73-85
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Rohrich RJ, Monheit G, Nguyen AT, Brown SA, Fagien S. Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg 2010; 125 (4) 1250-1256
    PubMedGoogle Scholar
  • 43 Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29 (1) 34-48
    CrossrefPubMedGoogle Scholar
  • 44 van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 2001; 72 (6) 557-571
    CrossrefPubMedGoogle Scholar
  • 45 Hoffmann N, Lee B, Hentzer M , et al. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother 2007; 51 (10) 3677-3687
    CrossrefPubMedGoogle Scholar
  • 46 Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg 2006; 118 (3, Suppl): 92S-107S
    CrossrefPubMedGoogle Scholar
  • 47 Cukier J, Beauchamp RA, Spindler JS, Spindler S, Lorenzo C, Trentham DE. Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med 1993; 118 (12) 920-928
    CrossrefPubMedGoogle Scholar
  • 48 Cooperman L, Michaeli D. The immunogenicity of injectable collagen. I. A 1-year prospective study. J Am Acad Dermatol 1984; 10 (4) 638-646
    CrossrefPubMedGoogle Scholar
  • 49 Cooperman L, Michaeli D. The immunogenicity of injectable collagen. II. A retrospective review of seventy-two tested and treated patients. J Am Acad Dermatol 1984; 10 (4) 647-651
    CrossrefPubMedGoogle Scholar
  • 50 Ellingsworth LR, DeLustro F, Brennan JE, Sawamura S, McPherson J. The human immune response to reconstituted bovine collagen. J Immunol 1986; 136 (3) 877-882
    PubMedGoogle Scholar
  • 51 Hanke CW, Thomas JA, Lee WT, Jolivette DM, Rosenberg MJ. Risk assessment of polymyositis/dermatomyositis after treatment with injectable bovine collagen implants. J Am Acad Dermatol 1996; 34 (3) 450-454
    CrossrefPubMedGoogle Scholar
  • 52 Rosenberg MJ, Reichlin M. Is there an association between injectable collagen and polymyositis/dermatomyositis?. Arthritis Rheum 1994; 37 (5) 747-753
    CrossrefPubMedGoogle Scholar